# A Study to Compare Two Different Formulations of Lasmiditan in Healthy Participants

> **NCT04881747** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 47 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Lasmiditan

## Key facts

- **NCT ID:** NCT04881747
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-14
- **Primary completion:** 2021-07-24
- **Final completion:** 2021-07-24
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2023-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04881747

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04881747, "A Study to Compare Two Different Formulations of Lasmiditan in Healthy Participants". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT04881747. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*